1-5 of 5
Brian J. Miles
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

GLIPR1 Tumor Suppressor Gene Expressed by Adenoviral Vector as Neoadjuvant Intraprostatic Injection for Localized Intermediate or High-Risk Prostate Cancer Preceding Radical Prostatectomy

Guru Sonpavde, Timothy C. Thompson, Rajul K. Jain, Gustavo E. Ayala, Shinji Kurosaka, Kohei Edamura, Ken-ichi Tabata, Chengzhen Ren, Alexei A. Goltsov, Martha P. Mims, Teresa G. Hayes, Michael M. Ittmann, Thomas M. Wheeler, Adrian Gee, Brian J. Miles, Dov Kadmon
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (22): 7174–7182.
https://doi.org/10.1158/1078-0432.CCR-11-1899
Published: 14 November 2011
View articletitled, GLIPR1 Tumor Suppressor Gene Expressed by Adenoviral Vector as Neoadjuvant Intraprostatic Injection for Localized Intermediate or High-Risk Prostate Cancer Preceding Radical Prostatectomy
Open the PDF for GLIPR1 Tumor Suppressor Gene Expressed by Adenoviral Vector as Neoadjuvant Intraprostatic Injection for Localized Intermediate or High-Risk Prostate Cancer Preceding Radical Prostatectomy in another window
Journal Articles

Cancer-Related Axonogenesis and Neurogenesis in Prostate Cancer

Gustavo E. Ayala, Hong Dai, Michael Powell, Rile Li, Yi Ding, Thomas M. Wheeler, David Shine, Dov Kadmon, Timothy Thompson, Brian J. Miles, Michael M. Ittmann, David Rowley
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (23): 7593–7603.
https://doi.org/10.1158/1078-0432.CCR-08-1164
Published: 01 December 2008
View articletitled, Cancer-Related Axonogenesis and Neurogenesis in Prostate Cancer
Open the PDF for Cancer-Related Axonogenesis and Neurogenesis in Prostate Cancer in another window
Journal Articles

Bortezomib-Mediated Inhibition of Steroid Receptor Coactivator-3 Degradation Leads to Activated Akt

Gustavo Ayala, Jun Yan, Rile Li, Yi Ding, Timothy C. Thompson, Martha P. Mims, Teresa G. Hayes, Vivian MacDonnell, R. Garret Lynch, Anna Frolov, Brian J. Miles, Thomas M. Wheeler, J. Wade Harper, Ming-Jer Tsai, Michael M. Ittmann, Dov Kadmon
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (22): 7511–7518.
https://doi.org/10.1158/1078-0432.CCR-08-0839
Published: 14 November 2008
View articletitled, Bortezomib-Mediated Inhibition of Steroid Receptor Coactivator-3 Degradation Leads to Activated Akt
Open the PDF for Bortezomib-Mediated Inhibition of Steroid Receptor Coactivator-3 Degradation Leads to Activated Akt in another window
Includes: Supplementary data
Journal Articles

Preoperative Serum Caveolin-1 as a Prognostic Marker for Recurrence in a Radical Prostatectomy Cohort

Salahaldin A. Tahir, Anna Frolov, Teresa G. Hayes, Martha P. Mims, Brian J. Miles, Seth P. Lerner, Thomas M. Wheeler, Gustavo Ayala, Timothy C. Thompson, Dov Kadmon
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (16): 4872–4875.
https://doi.org/10.1158/1078-0432.CCR-06-0417
Published: 16 August 2006
View articletitled, Preoperative Serum Caveolin-1 as a Prognostic Marker for Recurrence in a Radical Prostatectomy Cohort
Open the PDF for Preoperative Serum Caveolin-1 as a Prognostic Marker for Recurrence in a Radical Prostatectomy Cohort in another window
Journal Articles

Selenium Accumulation in Prostate Tissue During a Randomized, Controlled Short-term Trial of l-Selenomethionine: a Southwest Oncology Group Study

Anita L. Sabichi, J. Jack Lee, Robert J. Taylor, Ian M. Thompson, Brian J. Miles, Catherine M. Tangen, Lori M. Minasian, Louis L. Pisters, John R. Caton, Joseph W. Basler, Seth P. Lerner, David G. Menter, James R. Marshall, E. David Crawford, Scott M. Lippman
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (7): 2178–2184.
https://doi.org/10.1158/1078-0432.CCR-05-0937
Published: 11 April 2006
View articletitled, Selenium Accumulation in Prostate Tissue During a Randomized, Controlled Short-term Trial of l-Selenomethionine: a Southwest Oncology Group Study
Open the PDF for Selenium Accumulation in Prostate Tissue During a Randomized, Controlled Short-term Trial of l-Selenomethionine: a Southwest Oncology Group Study in another window